文献速递胃肠动力与功能性疾病

认知行为治疗与教育对肠易激综合征患者疗效的相关因素

Factors Associated With Efficacy of Cognitive Behavior Therapy vs Education for Patients With Irritable Bowel Syndrome.
PubMed 文献 · Clin Gastroenterol Hepatol · 2018-10-26

分析436例肠易激综合征患者随机接受4或10次认知行为治疗或教育的数据,发现基线特质焦虑和焦虑敏感性与认知行为治疗相比教育的胃肠道症状改善相关;低或典型水平者认知行为治疗优势显著,高水平者差异无统计学意义。

要点

  • 低特质焦虑者认知行为治疗应答率71.3% vs 教育34.9%(P<.05)。
  • 低焦虑敏感性者认知行为治疗应答率71.7% vs 教育38.6%(P<.05)。
  • 高特质焦虑或高焦虑敏感性者认知行为治疗与教育应答率差异无统计学意义。

核心结论

  • 在难治性肠易激综合征患者中,基线特质焦虑和焦虑敏感性水平与认知行为治疗相比教育后胃肠道症状改善相关。

研究设计与样本

  • 分析肠易激综合征结局研究数据,436例肠易激综合征患者(平均年龄41岁,80%女性)随机接受10周内4或10次认知行为治疗或教育。

主要发现

  • 低特质焦虑者认知行为治疗应答率71.3% vs 教育34.9%(P<.05);低焦虑敏感性者71.7% vs 38.6%(P<.05)。
  • 基线典型特质焦虑者认知行为治疗应答率66.0% vs 教育47.1%(P<.05);典型焦虑敏感性者66.3% vs 47.1%(P<.05)。
  • 高特质焦虑者认知行为治疗应答率60.6% vs 教育59.2%,差异无统计学意义;高焦虑敏感性者60.9% vs 55.9%,差异无统计学意义。
  • 特质焦虑量表评分≤22分时认知行为治疗相比教育有统计学显著优势;焦虑敏感性量表评分≤29分时认知行为治疗相比教育有统计学显著优势。

临床怎么用

  • 作者认为这些发现和方法可能用于优化肠易激综合征患者的治疗选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Among patients with irritable bowel syndrome (IBS), it would be helpful to identify those most likely to respond to specific treatments, yet few factors have been identified that reliably predict positive outcome. We sought to identify pretreatment baseline characteristics that associate with gastrointestinal symptom improvement in patients who received empirically validated regimens of cognitive behavior therapy (CBT) or IBS education. METHODS: We analyzed data from the IBS Outcome Study, in which 436 patients with IBS (average age, 41 years; 80%, female) were randomly assigned to groups that received 4 or 10 sessions of cognitive behavior therapy or education over 10 weeks. Baseline data were collected from all participants on sociodemographic and clinical features and comorbidities. Interaction analyses used a modified linear probability model with Huber-White robust estimators to identify baseline factors that moderated as a function of treatment condition GI symptom improvement based on the IBS-version of the Clinical Global Impressions-Improvement Scale. RESULTS: Whether the primary outcome of IBS symptom improvement was rated by patients or physician assessors blind to treatment 2 weeks after it ended, higher percentages of patients had symptom improvement after CBT compared with EDU among those with low levels of trait anxiety (71.3% vs 34.9%; P < .05) or anxiety sensitivity (71.7% vs 38.6%; P < .05) and for those with baseline typical levels of trait anxiety (66.0% vs 47.1%; P < .05) or anxiety sensitivity (66.3% vs 47.1%; P < .05). For patients with high trait anxiety or anxiety sensitivity, the difference in percentage of responders to CBT vs EDU was non-significant for trait anxiety (60.6% vs 59.2%) and anxiety sensitivity (60.9% vs 55.9%). If patients scored at or below 22 on the Trait Anxiety Inventory, CBT had a statistically significant advantage over EDU. If patients scored at or below 29 on the Anxiety Sensitivity Inventory, there was a statistically significant advantage for CBT vs EDU. CONCLUSIONS: In analyses of outcomes of patients with treatment-refractory IBS, baseline levels of trait anxiety and anxiety sensitivity (fear of arousal symptoms) were associated with improved gastrointestinal symptoms following CBT compared to IBS education. These findings and approaches might be used to optimize selection of treatment for patients with IBS.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Lackner JM, Jaccard J. Factors Associated With Efficacy of Cognitive Behavior Therapy vs Education for Patients With Irritable Bowel Syndrome. Clin Gastroenterol Hepatol. 2018. PMID: 30613000. doi:10.1016/j.cgh.2018.10.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。